Gene therapy trials can often be held back by cost and complexity. New database ...
Biomanufacturers must tread carefully when seeking the optimum solution for thei...
AbbVie has maintained a strong position within the immunology space for the past...
The new funding is set to fund the expansion of the company’s Phase IIb studies ...
The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart ...
In January, the US House Select Committee on the Strategic Competition between t...
Scorpion Therapeutics has secured $150m in a Series C financing round to progres...
China’s NMPA has granted approval for Zai Lab and argenx's efgartigimod SC for t...
The US FDA has issued a complete response letter (CRL) to Orexo regarding its ND...
Approval of tabelecleucel would mark the first available therapy for the treatme...
AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso...
The company will initiate Phase Ib and Phase II studies in major depression in 2...
AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment...
Global vaccine coverage is yet to return to levels seen in 2019, shortly before ...
Nona Biosciences has partnered with biotechnology company Alaya.bio to work on a...
Australia is fast becoming the place to be for innovative life sciences companie...
